The Reducer has been added to the European Society of Cardiology Practice Guidelines at the highest recommendation class for therapies addressing refractory angina. Learn More >
Positive results from the COSIRA clinical trial. Learn More >
Access our library of publications about the ReducerTM here >
This device is currently only available in the EU.
Note: The CCS class is a functional classification used to stratify the severity of angina by evaluating angina symptoms with activity levels. N Eng J Med 2015;372:519-527